Nomura Holdings’s Amicus Therapeutics FOLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-22,168
Closed -$143K 1630
2025
Q1
$181K Buy
+22,168
New +$205K ﹤0.01% 1667
2019
Q3
Sell
-82,500
Closed -$1.02M 1257
2019
Q2
$1.02M Buy
+82,500
New +$1.05M ﹤0.01% 837
2018
Q2
Sell
-580,260
Closed -$8.68K 1376
2018
Q1
$8.68K Buy
580,260
+465,060
+404% +$7.08M 0.01% 433
2017
Q4
$1.65M Sell
115,200
-76,000
-40% -$1.04M ﹤0.01% 951
2017
Q3
$2.88M Buy
+191,200
New +$2.53M 0.01% 730
2015
Q3
Sell
-28,233
Closed -$399K 1739
2015
Q2
$399K Sell
28,233
-3,332
-11% -$40.1K ﹤0.01% 1343
2015
Q1
$345K Buy
31,565
+7,934
+34% +$69.9K ﹤0.01% 1240
2014
Q4
$196K Sell
23,631
-694
-3% -$4.76K ﹤0.01% 2068
2014
Q3
$145K Sell
24,325
-112,490
-82% -$589K ﹤0.01% 2486
2014
Q2
$457K Buy
136,815
+125,368
+1,095% +$294K ﹤0.01% 1841
2014
Q1
$23K Sell
11,447
-25,858
-69% -$64.7K ﹤0.01% 2642
2013
Q4
$88K Buy
37,305
+2,212
+6% +$4.86K ﹤0.01% 1846
2013
Q3
$82K Sell
35,093
-2,063
-6% -$5.18K ﹤0.01% 2087
2013
Q2
$86K Buy
+37,156
New +$114K ﹤0.01% 2008

Other funds holding FOLD

Nomura Holdings's FOLD Position: Q2 2025 in Review

Nomura Holdings sold out of Amicus Therapeutics (FOLD) in Q2 2025, closing a stake of 22,168 shares — an estimated $143K sold.

Nomura Holdings first reported a position in FOLD in Q2 2013 and held it in 14 quarters. The position peaked at $2.88M in Q3 2017. 272 funds tracked by Wall St. Rank hold FOLD as of Q2 2025.

  • Nomura Holdings reported no remaining Amicus Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Nomura Holdings sold 22,168 Amicus Therapeutics shares in Q2 2025, an estimated $143K.
  • Nomura Holdings first reported a position in Amicus Therapeutics in Q2 2013 and held it in 14 quarters.
  • Nomura Holdings's Amicus Therapeutics position peaked at $2.88M in Q3 2017.
  • 272 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2025.

Based on Nomura Holdings's 13F filing for Q2 2025, filed 14 Aug 2025.